Signaling pathways
-
BA8862 CSF1R-IN-12Summary: CSF1R-IN-12 is a potent inhibitor. - BA8863 SYHA1813Summary: SYHA1813 is a dual inhibitor.
- BA8864 BezuclastinibSummary: Bezuclastinib (CGT9486) is an orally active, highly selective tyrosine kinase inhibitor with potent anti-activity.
- BA8865 AZD3229Summary: AZD3229 is a potent and broadly available mutant tyrosine kinase receptor inhibitor for developmental studies of gastrointestinal mesenchymal tumors.
- BA8866 M4205Summary: M4205 is an inhibitor.
- BA8867 c-Kit-IN-1Summary: c-Kit-IN-1 is a potent inhibitor.
- BA8868 ElenestinibSummary: Elenestinib (BLU-263) is a potent orally active tyrosine kinase inhibitor.
- BA8869 AC710Summary: AC710 is an effective inhibitor.
- BA8870 c-Kit-IN-5-1Summary: c-Kit-IN-5 is a potent inhibitor.
-
BA8871 JNJ-38158471Summary: JNJ-38158471 is a well-tolerated, orally active, highly selective inhibitor.